Arash Etemadi1,2, Hooman Khademi2,3, Farin Kamangar2,4, Neal D Freedman1, Christian C Abnet1, Paul Brennan3, Reza Malekzadeh2,5. 1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA. 2. Digestive Oncology Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. 3. International Agency for Research on Cancer, Lyon, France. 4. Department of Public Health Analysis, School of Community Health and Policy, Morgan State University, Baltimore, Maryland, USA. 5. Liver and Pancreaticobilliary Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Abstract
BACKGROUND: There is limited information about the hazards of cigarettes, smokeless tobacco and waterpipe in the Middle East. The aim of this study was to determine the association between different types of tobacco use and earlier death in the Golestan Cohort Study. METHODS: The Study includes 50 045 adults (aged 40-75 years) from north eastern Iran. The baseline questionnaire (2004-2008) assessed information about use of cigarettes, chewing tobacco (nass) and waterpipe. To assess the use of each type of tobacco compared with never tobacco users, we used Cox regression models adjusted for age, socioeconomic status, area of residence, education and other tobacco used, and stratified by sex, ethnicity and opium use. RESULTS: 17% of participants reported a history of cigarette smoking, 7.5% chewing tobacco (nass) and 1.1% smoking waterpipe, and these figures declined in the later birth cohorts. During a median follow-up of 8 years, 4524 deaths occurred (mean age 64.8+9.9 years). Current (HR=1.44; 95% CI 1.28 to 1.61) and former (HR=1.35; 95% CI 1.16 to 1.56) cigarette smokers had higher overall mortality relative to never tobacco users. The highest cigarette-associated risk was for cancer death among current heavy smokers (HR=2.32; 95% CI 1.66 to 3.24). Current nass chewing was associated with overall mortality (HR=1.16; 95% CI 1.01 to 1.34), and there was a 61% higher risk of cancer death in people chewing nass more than five times a day. We observed an association between the cumulative lifetime waterpipe use (waterpipe-years≥28) and both overall (HR=1.66; 95% CI 1.11 to 2.47), and cancer mortality (HR=2.82; 95% CI 1.30 to 6.11). CONCLUSIONS: Regular use of cigarettes, smokeless tobacco and waterpipe were associated with the risk of earlier death (particularly from cancer) in our cohort. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND: There is limited information about the hazards of cigarettes, smokeless tobacco and waterpipe in the Middle East. The aim of this study was to determine the association between different types of tobacco use and earlier death in the Golestan Cohort Study. METHODS: The Study includes 50 045 adults (aged 40-75 years) from north eastern Iran. The baseline questionnaire (2004-2008) assessed information about use of cigarettes, chewing tobacco (nass) and waterpipe. To assess the use of each type of tobacco compared with never tobacco users, we used Cox regression models adjusted for age, socioeconomic status, area of residence, education and other tobacco used, and stratified by sex, ethnicity and opium use. RESULTS: 17% of participants reported a history of cigarette smoking, 7.5% chewing tobacco (nass) and 1.1% smoking waterpipe, and these figures declined in the later birth cohorts. During a median follow-up of 8 years, 4524 deaths occurred (mean age 64.8+9.9 years). Current (HR=1.44; 95% CI 1.28 to 1.61) and former (HR=1.35; 95% CI 1.16 to 1.56) cigarette smokers had higher overall mortality relative to never tobacco users. The highest cigarette-associated risk was for cancer death among current heavy smokers (HR=2.32; 95% CI 1.66 to 3.24). Current nass chewing was associated with overall mortality (HR=1.16; 95% CI 1.01 to 1.34), and there was a 61% higher risk of cancer death in people chewing nass more than five times a day. We observed an association between the cumulative lifetime waterpipe use (waterpipe-years≥28) and both overall (HR=1.66; 95% CI 1.11 to 2.47), and cancer mortality (HR=2.82; 95% CI 1.30 to 6.11). CONCLUSIONS: Regular use of cigarettes, smokeless tobacco and waterpipe were associated with the risk of earlier death (particularly from cancer) in our cohort. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Entities:
Keywords:
Global health; Low/Middle income country; Non-cigarette tobacco products; Smoking Caused Disease
Authors: Abla M Sibai; Rania A Tohme; Mohamad M Almedawar; Taha Itani; Sara I Yassine; Eden A Nohra; Hussain A Isma'eel Journal: Atherosclerosis Date: 2014-04-15 Impact factor: 5.162
Authors: Hooman Khademi; Reza Malekzadeh; Akram Pourshams; Elham Jafari; Rasool Salahi; Shahryar Semnani; Behrooz Abaie; Farhad Islami; Siavosh Nasseri-Moghaddam; Arash Etemadi; Graham Byrnes; Christian C Abnet; Sanford M Dawsey; Nicholas E Day; Paul D Pharoah; Paolo Boffetta; Paul Brennan; Farin Kamangar Journal: BMJ Date: 2012-04-17
Authors: Gary A Giovino; Sara A Mirza; Jonathan M Samet; Prakash C Gupta; Martin J Jarvis; Neeraj Bhala; Richard Peto; Witold Zatonski; Jason Hsia; Jeremy Morton; Krishna M Palipudi; Samira Asma Journal: Lancet Date: 2012-08-18 Impact factor: 79.321
Authors: Arash Etemadi; Hossein Poustchi; Cindy M Chang; Benjamin C Blount; Antonia M Calafat; Lanqing Wang; Victor R De Jesus; Akram Pourshams; Ramin Shakeri; Meredith S Shiels; Maki Inoue-Choi; Bridget K Ambrose; Carol H Christensen; Baoguang Wang; Gwen Murphy; Xiaoyun Ye; Deepak Bhandari; Jun Feng; Baoyun Xia; Connie S Sosnoff; Farin Kamangar; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh; Neal D Freedman Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-01-08 Impact factor: 4.254
Authors: Arash Etemadi; Hossein Poustchi; Antonia M Calafat; Benjamin C Blount; Victor R De Jesús; Lanqing Wang; Akram Pourshams; Ramin Shakeri; Maki Inoue-Choi; Meredith S Shiels; Gholamreza Roshandel; Gwen Murphy; Connie S Sosnoff; Deepak Bhandari; Jun Feng; Baoyun Xia; Yuesong Wang; Lei Meng; Farin Kamangar; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh; Neal D Freedman Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-01-08 Impact factor: 4.254
Authors: Arash Etemadi; Abdullah Gandomkar; Neal D Freedman; Mohsen Moghadami; Mohammad Reza Fattahi; Hossein Poustchi; Farhad Islami; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh Journal: Int J Epidemiol Date: 2017-12-01 Impact factor: 7.196
Authors: Farhad Islami; Hossein Poustchi; Akram Pourshams; Masoud Khoshnia; Abdolsamad Gharavi; Farin Kamangar; Sanford M Dawsey; Christian C Abnet; Paul Brennan; Mahdi Sheikh; Masoud Sotoudeh; Arash Nikmanesh; Shahin Merat; Arash Etemadi; Siavosh Nasseri Moghaddam; Paul D Pharoah; Bruce A Ponder; Nicholas E Day; Ahmedin Jemal; Paolo Boffetta; Reza Malekzadeh Journal: Int J Cancer Date: 2019-03-20 Impact factor: 7.316